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ABSTRACT 
 
 
 This research has evaluated the rheological properties of two types of materials 
which include (i) semi-synthetic polymer-based injectable hydrogels [P(NIPAAm-co-
DEX-Lactate HEMA) and P(NIPAAm-co-HA-AEMA)], and (ii) biological tissues 
(porcine ocular tissues).  
 
A series of thermoresponsive and biodegradable in situ hydrogel based on N-
isopropyacrylamide (NIPAAm) monomer and hydrolytically degradable oligolactate 
Dextran-lactate-HEMA or Hyaluronic acid (HA)-AEMA macromer were investigated as 
encapsulation matrices (scaffolds) for DPSCs/ADSCs and assess their applicability in 
dental/retinal tissue engineering. The rheological properties of the hydrogels were 
strongly dependent on the reaction conditions and composition of the hydrogels. Both the 
hydrogels exhibited linear viscoelasticity, and the values of storage moludus (G´) at 1 Hz 
appeared in the range of 15-35 Pa for P(NIPAAm-co-DEX-Lactate HEMA) gels and 20-
40 Pa for P(NIPAAm-co-HA-AEMA) gels at 15 mg·mL-1 concentration. No significant 
differences were found for the hydrogels prepared with the HA or dextran at the same 
concentration and monomer to macromer ratio (19:1). The hydrogels were nontoxic to 
DPSCs and ADSCs at a concentration up to 15 mg·mL-1, and in vitro survival studies 
using MTT and DAPI indicated that both DPSCs and ADSCs have favorably adhered and 
proliferated within the dextran and HA-based hydrogels. Survival of the DPSCs/ADSCs 
in the hydrogels, growth and morphology make these scaffolds a viable option for using 
as a biological scaffold for tissue engineering. 
 
Since the functionality of the ocular tissues closely depends on their 
biomechanical properties, the rheological properties of the ocular tissues at different 
stages of development (preterm, neonatal and adult stage) is of therapeutic interest and 
has not been thoroughly investigated. This study has investigated the shear properties of 
porcine cornea, sclera and vitreous under strain and frequency sweep. All three tissue 
types at different stages have shown linear viscoelastic region under strain sweep. The G´ 
of cornea and vitreous weakly varied between neonatal and preterm, however, the adult 
cornea (~1.3-fold) and vitreous (~1.8-fold) showed significant higher moduli. On the 
other hand, the G´ of the sclera increased significantly with the developmental stage of 
the tissue, (preterm <neonatal (~1.9-fold) < adult (17.4-fold)). Thus, the rheological 
properties of the porcine ocular tissues varied with the developmental stage of the tissue. 
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CHAPTER 1.    INTRODUCTION 
 
 
This research has evaluated the rheological properties of two types of materials 
which include (i) semi-synthetic polymer-based injectable hydrogels [P(NIPAAm-co-
DEX-Lactate HEMA) and P(NIPAAm-co-HA-AEMA)], and (ii) biological tissues 
(porcine ocular tissues). 
 
 
PNIPAAm-Based (Thermoresponsive) Injectable Hydrogels 
 
Among the injectable hydrogels, in situ hydrogels formed by thermoresponsive 
phase transition have gained extensive attention because the gelation can be triggered as 
the temperature rises above the lower critical solution temperature (LCST) of the polymer 
[1]. LCST can be designed below body temperature so that the sol-gel phase transition of 
injectable systems get triggered at the physiological condition (37C) [2]. PNIPAAm is a 
typical thermosensitive polymer used in the synthesis of various hydrogels [3]. Below 
LCST, PNIPAAm is hydrophilic and remains in a soluble state in aqueous solution, but 
with an increase in the temperature above LCST it undergoes a phase transition and 
forms a hydrogel [4]. Several studies have shown that the phase behavior and mechanical 
properties of PNIPAAm hydrogels can be modified by the addition of hydrophobic or 
hydrophilic monomers to impart desired properties into the material [2, 5, 6]. Various 
composite hydrogel systems were reported in the literature by modifying the PNIPAAm 
with poly(ethylene glycol), chitosan, hyaluronic acid, chondroitin sulfate or other 
polymers to alter its physicochemical/ biological/mechanical properties such as to 
preserve the viability and phenotypic morphology of the cells, improve proliferation, 
differentiation and extracellular matrix secretion of the cells entrapped within the 
hydrogel, provide mechanical properties for providing ambient environment for 
supporting the cell growth [5-11].   
 
Although promising, the thermoresponsive NIPAAm homopolymer are not 
biodegradable. It is more advantageous to introduce degradable property into the 
PNIPAAm-based scaffolds as degradation of the hydrogel matrix not only circumvents 
removal of the empty device but also can be used to modulate space in response to the 
tissue regeneration and nutrient diffusion. Also, when the polymer slowly degrades, the 
cells will be able to produce their own ECM and generate successful cell-polymer graft. 
Therefore, in this study, we designed and synthesized injectable thermoresponsive and 
biodegradable hydrogels by copolymerizing NIPAAm monomer with dextran-lactate-2-
hydroxyethyl methacrylate (DEX-Lactate-HEMA) or HA-aminoethylmethacrylate (HA-
AEMA) macromer using the synthetic technique. Because of the existence of a 
hydrolyzable/enzymatically degradable DEX-Lactate/HA in the prepolymer mixture, 
biodegradable crosslinks can be formed within the PNIPAAm hydrogel systems, 
resulting in biodegradable thermoresponsive systems.  Dextran and HA used in the study 
for modifying PNIPAAm are naturally occurring biodegradable polymers. Dextran is a 
natural polysaccharide that is enzymatically degradable by dextranases [12]. Dextran is 
commercially available in wide range of MWs with relatively narrow MW distribution. It 
 2 
has been successfully used for various tissue engineering applications because of its 
excellent biocompatibility, biodegradability, hydrophilicity, stability under slightly acidic 
and basic conditions, and surface hydroxyl functionality for conjugation [13-16]. Several 
reports have been published on altering the dextran properties to make various dextran 
graft polymers via various chemical modifications for various applications [12]. HA is 
one of the major glycosaminoglycan polysaccharides in the ECM of the newly developed 
dentin, pulp tissues, and vitreous humor, and is enzymatically degradable by 
hyaluronidase. The biocompatible structure, biodegradation rate of HA and the flexibility 
to modify structurally and chemically has suggested its suitability as a scaffold for 
DPSCs/ADSCs in tissue engineering applications [5, 17-20].  
 
 
Hypothesis and Specific Aims  
 
The long-term goal of the project is to develop biomaterials for dental and retinal 
tissue engineering. The short-term goal of this project was to design and develop 
injectable thermoresponsive and biodegradable hydrogels P(NIPAAm,-co-DEX-Lactate-
HEMA) and P(NIPAAm-co-Hyaluronic acid AEMA) as scaffolds for encapsulating 
DPSCs/ADSCs for dental and retinal tissue engineering applications. Also, to investigate 
whether the scaffold material properties can be controlled by polymer modification and 
whether cell viability and growth could be improved. The hypothesis of this research was 
that the injectable biodegradable P(NIPAAm-co-DEX-Lactate-HEMA) and P(NIPAAm-
co-HA-AEMA) hydrogels were nontoxic to DPSCs and ADSCs cells and promote their 
growth inside the matrices. 
 
 
Specific Aim 1  
 
To synthesize and characterize P(NIPAAm-co-DEX-Lactate-HEMA) and 
P(NIPAAm-co-HA-AEMA) hydrogels by UV polymerization and FTIR. A series of 
biodegradable P(NIPAAm-co-DEX-Lactate-HEMA) and p(NIPAAm-co-HA-AEMA) 
hydrogels were synthesized with varying monomer/macromer ratios, initiator 
concentration, UV intensity, and reaction times. The hydrogels were characterized for 
sol-gel transition and rheological properties.  
 
 
Specific Aim 2  
 
To evaluate in vitro cytotoxicity and encapsulation capabilities of P(NIPAAm-co-
DEX-Lactate-HEMA) and P(NIPAAm-co-HA-AEMA) hydrogels. In vitro cytotoxicity 
of hydrogels to DPSCs and ADSCs was tested at various concentrations of the hydrogel 
in cell growth medium by MTT assay. The growth of DPSCs/ADSCs inside the hydrogel 
matrix was examined using MTT and DAPI assays. 
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Rheological Studies of Porcine Ocular Tissues 
 
The proper vision of the eye strongly depends on its ability to maintain optical 
clarity and structural integrity under routine variations in pressure, changes in humidity 
and temperature, constant muscular stress/strain and rapid sudden movements. Thus the 
proper functioning of the eye is dependent on its physical and mechanical properties, and 
altered chemical and mechanical states of ocular tissues could lead to abnormalities and 
may result in complete loss of the functionality. Various age-related changes in 
composition and structure of the eye tissues affect the biomechanical properties and 
performance of the eye tissues and could contribute to the predisposition of various eye 
abnormalities [21-26]. For example, aging results in stiffening of the cornea tissue which 
could be because of the additional age-related non-enzymatic cross-linking affecting the 
stromal collagen fibrils [24, 25]. It is reported in the literature that age-related variations 
affect the biomechanical characteristics of the sclera [21], and aging results in the 
microstructural changes in the sclera and contribute to the predisposition to primary 
open-angle glaucoma [22].  With age, collagen networks in the vitreous begin to break 
down and pockets of liquid form in the eye, the process of liquefaction in which the 
liquid volume increases and gel volume decreases [23, 26]. These age-related changes 
could lead to structural and mechanical differences between vitreous at various stages of 
development, and in about 25-30% of the population, these age-related degenerative 
changes eventually result in posterior vitreous detachment [27]. Given the importance of 
the viscoelastic properties of the ocular tissues, to its function and to pathology, detailed 
rheological characterization of these tissues is crucial to appreciate the normal functions 
and quantitative understanding of disease pathophysiology of these tissues at various 
stages of development. The objective of this project was to characterize the rheological 
properties of the ocular tissues (cornea, sclera and vitreous) at different stages (preterm, 
neonatal and adult) of development. Though several measurements could be measured in 
vivo, such as topography, thickness distribution, but the attempts to investigate the 
biomechanical properties of the tissues still depend on ex-vivo experiments involving 
human or other animal tissues [28]. Because of the difficulties in obtaining human donor 
tissues in sufficient numbers for the research and experimental needs, it had been 
necessary to use animal ocular tissues as approximate models for human ocular tissues 
for performing various evaluations including the mechanical property characterization 
studies. Several investigations used porcine tissues for ocular related experiments [28-
30], although other animal’s rabbit and bovine tissues a common practice. Therefore, the 
current rheological characterization also contributes to the literature for identifying and 
assessing the important similarities and significant differences between the rheological 
behaviors of porcine ocular tissues and human and other animal tissues and evaluating 
the suitability of the porcine eye tissues as a model of the human tissues.  
 
 
Hypothesis and Specific Aims  
 
The hypothesis of this project was that the storage and loss modulus of the 
porcine ocular tissues differ at different stages of development (preterm, neonatal and 
adult). There were two specific aims: 
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Specific Aim 1  
 
To conduct the shear-sweep experiments and identify the linear viscoelastic 
region of the porcine ocular tissues (cornea, sclera, vitreous) at different stages of 
development (preterm, neonatal, adult). 
 
 
Specific Aim 2 
 
To conduct the frequency sweep experiment and analyze the gel-like behaviors of the 
porcine ocular tissues (cornea, sclera, vitreous) at different stages of development 
(preterm, neonatal, adult). 
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CHAPTER 2.    SYNTHESIS AND CHARACTERIZATION OF INJECTABLE 
THERMORESPONSIVE AND BIODEGRADABLE HYDROGELS FOR STEM 
CELL-BASED TISSUE ENGINEERING 
 
 
Introduction 
 
 
Stem-Cell Based Therapy 
 
Organ failure disorders and several of neurodegenerative diseases characterized 
by death of cells are leading to the irreversible loss of tissues and functions. For many of 
the neurodegenerative diseases, particularly in those conditions where an extensive cell 
loss was occurred prior to molecular level diagnosis of their gene defects, just the drug 
and/or gene therapy may not be enough to resolve the issues [31]. In such instances, the 
strategies were focused on cellular or tissue replacement, and based on recent studies, it 
was found that these strategies were beneficial [31-33]. Cell-based therapy involves the 
use of exogenous cells obtained from either autologous or allogenic source [34]. In such 
cases, use of stem/progenitor cells presents major advantages over differentiated cells as 
they can proliferate to the required amounts before or after transplantation [34].   
 
Even though the stem-cell based therapies are promising, still they need an 
effective transplantation system.  Current direct delivery methods could result in massive 
cell loss and limited cellular integration following transplantation [31]. For example, 
studies indicated that after bolus injection of photoreceptor cells, less than 0.01% of 
transplanted cells survive and even fewer actually integrate within the host retina [35, 
36]. Therefore, there is a need for efficient delivery methods that could minimize the cell 
loss and assist in the growth and cell integration into the host system, and tissue 
engineering scaffolds are the alternative option that has shown to help in addressing the 
above-mentioned issues [37-39]. 
 
 
Tissue Engineering 
 
Since its first use as a term in the mid-1980s, tissue engineering has moved from 
‘science-fiction’ concept to ‘science fact’ and emerged as a significant multidisciplinary 
field in the biotechnological area, with the research-oriented acceptance of its potential to 
regulatory approvals and market availability for the treatment [40]. Especially, with a 
more significant advancement of biomaterials, tissue engineering is emerging as a great 
potential alternative or complementary solution for restoring, maintaining or improving 
tissue or organ functions [41]. A general tissue engineering paradigm involves the use of 
a highly porous artificial extracellular matrix or ‘scaffold’ as a temporary support matrix 
for cell growth, differentiation, and matrix production, and the resulting tissue 
engineering construct is then grafted back in vivo into the subject. These constructs are 
either fully functional or they grow into the required functionality [41, 42]. Thus, tissue 
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engineering has the promising potential to revolutionize methods in medical treatment 
and can offer a long-term solution for many age-related conditions. 
 
In simple terms, scaffolds are porous artificial materials functioning as an 
extracellular matrix that accommodates and guides the growth and proliferation of cells 
in the 3D environment [39, 42]. The native extracellular matrix (ECM) not only provides 
physical support or appropriate architecture to the cells but also functions as a substrate 
for cell adhesion, migration and controls cellular proliferation and supplies with various 
growth factors and nutrients. In order to guide the formation of tissues with a required 
structural and functional characteristics, it is essential to provide a dynamic in vitro 
microenvironment with a proper quantity of physical strength such as shear and 
mechanical forces that promote their development [43]. Therefore, the key objective of a 
scaffold is to closely mimic the native ECM environment in terms of physical structure, 
chemical composition, and biological functions and play a similar role for promoting 
tissue regeneration in vitro as native ECM does in vivo [41]. Overall, the desirable 
physical characteristics of biomaterial scaffold for tissue engineering applications include 
nontoxic/non-inflammatory, hydrophilicity, high porosity with uniformly distributed 
interconnected pores throughout the matrix, large surface area, large pore size, and the 
ability to degrade in response to tissue repair and growth progresses, ideal shear and 
mechanical support as native environment [44-46].  
 
 
Dental and Retinal Tissue Engineering 
 
Data on tooth loss showed that at least 20 million people in the US have missed 
all of their teeth, and more than 100 million have lost 11–15 teeth [47]. Dental tissue 
engineering, to regenerate the dental pulp or dentin tissues in the pulp space of teeth, has 
grown tremendously as a new option in the area of endodontics for preserving and 
restoring the teeth [34, 48]. Although dentine can regenerate, the pulp has a limited 
capability for regeneration as it is encased in dentine and has limited apical blood supply 
[49]. Dental pulp stem cells (DPSCs) are an accessible multipotent stem cell source with 
therapeutic applicability in repair and regeneration of damaged tissues [50]. Dr. Huang’s 
group has demonstrated that DPSCs are a promising source for dental tissue regeneration 
(dentin-pulp like tissues, bioroot) [51]. Also because of their angiogenic and 
angioinductive property, they are a good source for non-dental (bonelike tissues, 
neurogenic, angiogenic) tissue engineering applications as well [34]. Studies conducted 
on dental pulp tissue regeneration, utilizing the DPSCs seeded PLGA-based synthetic 
preformed scaffolds, have shown the formation of pulp-like tissue in both in vitro and in 
vivo models. However, due to the smaller size and encasement of the dental pulp inside 
the root canal, utilizing an injectable scaffold that can be administered into the enclosed 
area could complement the efficiency of the DPSCs-based therapy for engineering the 
dentine-pulp complex by minimizing the cell loss and assisting in the growth and cell 
integration into the host system upon administration. 
 
Retinal degenerations are a group of conditions that can lead to permanent visual 
loss and affect millions of people worldwide [52]. Clinically, there are no neuroprotective 
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nor axogenic therapies are available that can restore lost visual functionality in retinal 
degenerative diseases [53]. Current therapeutic strategies such as anti-angiogenic drugs, 
anti-inflammatory, and gene therapy can delay the disease progression but not effective 
in permanent cure. Several studies are in progress aiming to regenerate the diseased retina 
by stem-cell transplantation for the replacement of lost retinal ganglion cells (RGCs) and 
photoreceptors. Currently, there are many ongoing clinical trials which aim to test the 
safety and efficacy of stem cell transplantation in the eye [52]. Several reports in the 
literature have suggested that the retinal tissue can be replaced and some degree of 
functional recovery can be regained following the delivery of stem-cells [54]. Adipose-
derived stem cells (ADSCs) are progenitor cells that can easily be isolated from adipose 
tissue [55]. They have the capability of self-renewal and multilineage differentiation and 
can be transplanted to either autologous or allogeneic body safely with less implant 
migration and foreign body reaction [20]. The ADSCs have functional and phenotypic 
overlap and plays a key role in providing vascular protection [20, 56, 57]. ADSCs are 
also known to produce angiogenic and antiapoptotic factors [55]. Recent findings from 
Dr. Gangaraju’s group on the regenerative therapeutic potential of ADSCs and showed 
that a single direct intravitreal injection of ADSCs significantly limited the development 
of diabetic ocular complications [55]. Intravitreal injection of ADSCs has shown to 
stabilize the retinal microvasculature, thereby enabling repair and regeneration of 
damaged capillaries in vivo [58].  The results suggested that ADSCs have great potential 
to be developed into a cell-based therapy to address both retinal capillary and 
neurodegeneration [55]. Earlier retinal transplantation studies involved direct injection of 
the cells into the vitreous or subretinal space with the assumption that the injected cells 
would migrate to the degenerated site of the retina, integrate within the host retina and 
restore vision functionality [52]. Despite promising outcomes of cell-based therapies to 
regenerate the degenerating retina, they also demonstrated that the direct bolus injection 
of stem cells in vivo could result in disorganized and poorly localized tissue grafts [59]. 
The resulted outcomes of low rates of cell survival due to poor donor cell integration and 
injection reflux are primarily related to the transplantation procedure [59]. Use of 
injectable hydrogel scaffolds for seeding and delivering the stems cells into the retina 
could be an attractive alternative to direct injection as they can potentially limit donor cell 
death due to injection reflux and help in improving the integration of the donor cells into 
host system [60]. 
 
Therefore, new biomaterials, injectable thermoresponsive and biodegradable 
hydrogel scaffolds, have been evaluated in this project for seeding DPSCs/ADSCs for 
dental/retinal tissue engineering applications. 
 
 
Injectable Hydrogel Biomaterials 
 
Biomaterials have been proved to significantly affect the proliferation and 
differentiation potential of stem cells by controlling physicochemical properties (e.g., 
surface charge, source, mechanical properties and microstructural patterns) [61]. In the 
recent years, significant efforts have been made to develop several biocompatible 
scaffolds for tissue engineering based on synthetic and natural polymers and studied to 
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improve the cell attachment, viability/proliferation, differentiation and growth of the 
DPSCs/ADSCs [44, 46, 62-65].  The synthetic polymers (polyglycolide (PLG) [66, 67], 
polylactide (PLA)[68, 69], polylactide-co-glycolide (PLGA) [70-72], polycaprolactone 
(PCL) [73], PNIPAAm-based possess much flexibility in terms of tailoring the 
architecture (scaffold shape, porosity, mechanical properties), controlling the degradation 
rate and have shown much success [74-76]. But the limitations include the risk of 
rejection rate due to cell and tissue necrosis due to degradation products of polymers [44, 
77]. Unlike synthetic polymer-based scaffolds, natural polymers (polysaccharides (e.g., 
chitin [78], chitosan [79-81], hyaluronic acid (HA) [17-19], alginate [82-85]) proteins 
(collagen [17, 86, 87], gelatin [84], fibrin [76]) are bioactive and promote cell growth and 
cell adhesion. Further, they are biodegradable thus can allow the host cells to grow and 
produce their own ECM and replace the degraded scaffold over time. Thus advantages of 
these single type of polymers have motivated the researchers to investigate combinatorial 
systems/composite scaffolds comprising multiple types of biomaterials [44]. Such 
examples include combining synthetic polymers with natural polymers [88, 89], for 
enhancing their biological capacity. These combinational systems can have controlled 
degradation, have a wide range of mechanical properties that enable them to be used in 
various tissue engineering applications. Since human tissue ranges in terms of mechanical 
properties, control of mechanical properties of the materials using a composite scaffold of 
synthetic and natural polymers will be greatly advantageous. 
 
Among various biomaterials, hydrogels represent an important class of scaffolds 
that have been explored for tissue engineering applications. These are 3-dimensional-
crosslinked hydrophilic polymeric networks that absorb and retain large amounts of water 
or biological fluids [90]. They possess several unique properties such as 3-dimensional 
network, tissue compatibility and similarity to native ECM, support cell proliferation and 
migration, controlled release of growth factors and nutrient diffusion [91].  They have 
gained significant attention for tissue engineering applications because of their attractive 
physicochemical properties such as hydrophilicity, water imbibing nature, softness, 
nutrient diffusion, and synthetic flexibility [91-93]. However, the traditional pre-formed 
hydrogel scaffold needs invasive procedures for administration and may have improper 
adaptation to the defect site which could lead to scaffold failure. Therefore, injectable 
biodegradable hydrogel biomaterials, which are liquids before injection and transform to 
a gel at the site of injection in response to external stimuli, have been extensively 
investigated as cell scaffolds owing to their advantages such as ease of administration 
with minimal invasiveness, less discomfort and less scarring, complete filling of the 
defect area with better adaptation and good permeability [94]. In addition, cells can be 
easily incorporated in the solution by mixing prior to injection under appropriate 
conditions, and after injection, they can take the shape of the cavity and fill irregular 
defects [92, 93]. Eliminating highly invasive procedures could lower the healthcare costs 
and improve the recovery time for the patients. 
 
Various physical and chemical mechanisms can be used to trigger this phase 
transition [94, 95]. Various types of injectable hydrogels have been investigated for the 
regeneration of i) cartilage tissues (using chondrocytes in: collagen [96], chitosan-
hyaluronic acid (HA) [97], methacrylated glycol chitosan-HA [98], gelatin–hydroxy 
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phenylpropionic acid [99], HA-PEG [100],  PEG-based [101], dextran-tyramine [13], 
HA-g-dextran-tyramine [15]), ii) intervertebral discs (using chondrocytes in: amidic 
alginate [102]; using mesenchymal stem cells in: HA–PNIPAAm [103], PHEMA-co-
aminopropyl methacrylamide (APMA))-graft-poly(amido amine) [104], HA-PEG [105]), 
iii) bone (using calvarial osteoblasts in: alginate hydrogels along with poly(aldehyde 
glucoronate) [106], RGD peptide modified alginate [107]; using human mesenchymal 
stem cells in: PCLA–PEG–PCLA [108], acrylated HA-PEG [109]; using osteoblasts in: 
RGD modified PEG hydrogel [110]; using marrow mesenchymal stem cells in: chitosan 
[111], chitin–PCL–nanoHAp [111], chitosan–alginate [112]); iv) adipose tissue (using 
adipose-derived stem cells in: PNIPAAM-HA [5], modified PEG [5], alginate-O-
carboxymethyl chitosan-fibrin [113]; using preadipocytes in: alginate hydrogels linked 
with RGD peptide [114, 115]), v) muscle tissues (using skeletal myoblasts in: fibrin [116, 
117], poly(d-valerolactone) (PVL)–PEG–PVL [118]; using cardiosphere derived cells in 
combination polymers PNIPAAm-PCL-HEMA-DBLA, Dex-PCL-HEMA/PNIPAAm 
[119, 120], using satellite cells in photo-crosslinkable HA [121], chitosan/beta-
glycerolphosphate/collagen [122]; using mesoangioblasts in: PEG-fibrinogen [123]; 
using ischaemic progenitor cells in: collagen, alginate, HA, chitosan [124, 125]); v) 
dental (using DPSCs in Puramatrix [126]).  
 
 
PNIPAAm-Based (Thermoresponsive) Injectable Hydrogels 
 
Among the injectable hydrogels, in situ hydrogels formed by thermoresponsive 
phase transition have gained extensive attention because the gelation can be triggered as 
the temperature rises above the lower critical solution temperature (LCST) of the polymer 
[1]. LCST can be designed below body temperature so that the sol-gel phase transition of 
injectable systems get triggered at the physiological condition (37C) [2]. PNIPAAm is a 
typical thermosensitive polymer used in the synthesis of various hydrogels [3]. Below 
LCST, PNIPAAm is hydrophilic and remains in a soluble state in aqueous solution, but 
with an increase in the temperature above LCST it undergoes a phase transition and 
forms a hydrogel [4]. Several studies have shown that the phase behavior and mechanical 
properties of PNIPAAm hydrogels can be modified by the addition of hydrophobic or 
hydrophilic monomers to impart desired properties into the material [2, 5, 6]. Various 
composite hydrogel systems were reported in the literature by modifying the PNIPAAm 
with poly(ethylene glycol), chitosan, hyaluronic acid, chondroitin sulfate or other 
polymers to alter its physicochemical/ biological/mechanical properties such as to 
preserve the viability and phenotypic morphology of the cells, improve proliferation, 
differentiation and extracellular matrix secretion of the cells entrapped within the 
hydrogel, provide mechanical properties for providing ambient environment for 
supporting the cell growth [5-11].   
 
Although promising, the thermoresponsive NIPAAm homopolymer are not 
biodegradable. It is more advantageous to introduce degradable property into the 
PNIPAAm-based scaffolds as degradation of the hydrogel matrix not only circumvents 
removal of the empty device but also can be used to modulate space in response to the 
tissue regeneration and nutrient diffusion. Also, when the polymer slowly degrades, the 
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cells will be able to produce their own ECM and generate successful cell-polymer graft. 
Therefore, in this study, we designed and synthesized injectable thermoresponsive and 
biodegradable hydrogels by copolymerizing NIPAAm monomer with dextran-lactate-2-
hydroxyethyl methacrylate (DEX-Lactate-HEMA) or HA-aminoethylmethacrylate (HA-
AEMA) macromer using the synthetic technique. Because of the existence of a 
hydrolyzable/enzymatically degradable DEX-Lactate/HA in the prepolymer mixture, 
biodegradable crosslinks can be formed within the PNIPAAm hydrogel systems, 
resulting in biodegradable thermoresponsive systems.  Dextran and HA used in the study 
for modifying PNIPAAm are naturally occurring biodegradable polymers. Dextran is a 
natural polysaccharide that is enzymatically degradable by dextranases [12]. Dextran is 
commercially available in wide range of MWs with relatively narrow MW distribution. It 
has been successfully used for various tissue engineering applications because of its 
excellent biocompatibility, biodegradability, hydrophilicity, stability under slightly acidic 
and basic conditions, and surface hydroxyl functionality for conjugation [13-16]. Several 
reports have been published on altering the dextran properties to make various dextran 
graft polymers via various chemical modifications for various applications [12]. HA is 
one of the major glycosaminoglycan polysaccharides in the ECM of the newly developed 
dentin, pulp tissues, and vitreous humor, and is enzymatically degradable by 
hyaluronidase. The biocompatible structure, biodegradation rate of HA and the flexibility 
to modify structurally and chemically has suggested its suitability as a scaffold for 
DPSCs/ADSCs in tissue engineering applications [5, 17-20].  
 
 
Hypothesis and Specific Aims 
 
The long-term goal of the project is to develop biomaterials for dental and retinal 
tissue engineering. The short-term goal of this project was to design and develop 
injectable thermoresponsive and biodegradable hydrogels P(NIPAAm,-co-DEX-Lactate-
HEMA) and P(NIPAAm-co-Hyaluronic acid AEMA) as scaffolds for encapsulating 
DPSCs/ADSCs for dental and retinal tissue engineering applications. Also, to investigate 
whether the scaffold material properties can be controlled by polymer modification and 
whether cell viability and growth could be improved. The hypothesis of this research was 
that the injectable biodegradable P(NIPAAm-co-DEX-Lactate-HEMA) and P(NIPAAm-
co-HA-AEMA) hydrogels were nontoxic to DPSCs and ADSCs cells and promote their 
growth inside the matrices. 
 
Specific Aim 1. To synthesize and characterize P(NIPAAm-co-DEX-Lactate-
HEMA) and P(NIPAAm-co-HA-AEMA) hydrogels by UV polymerization and FTIR. A 
series of biodegradable P(NIPAAm-co-DEX-Lactate-HEMA) and p(NIPAAm-co-HA-
AEMA) hydrogels were synthesized with varying monomer/macromer ratios, initiator 
concentration, UV intensity, and reaction times. The hydrogels were characterized for 
sol-gel transition and rheological properties.  
 
Specific Aim 2. To evaluate in vitro cytotoxicity and encapsulation capabilities of 
P(NIPAAm-co-DEX-Lactate-HEMA) and P(NIPAAm-co-HA-AEMA) hydrogels. In 
vitro cytotoxicity of hydrogels to DPSCs and ADSCs was tested at various concentrations 
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of the hydrogel in cell growth medium by MTT assay. The growth of DPSCs/ADSCs 
inside the hydrogel matrix was examined using MTT and DAPI assays. 
 
 
Materials and Methods 
 
 
Chemicals and Reagents 
 
Dextran (MW -15,000 g·mol-1) was purchased from Polysciences, Inc., 
Warrington, PA. Hyaluronic Acid (HA) was provided by Bloomage Freda Biopharm Co., 
Ltd., Jinan, China. The following materials were obtained from Sigma–Aldrich, Inc (St. 
Louis, MO): N-isopropylacrylamide (NIPAAm), 2-hydroxyethyl methacrylate (HEMA), 
4-(N,N-dimethylamino) pyridine (DMAP), N,N’-carbonyl diimidazole (CDI), L-lactide, 
stannous octoate (SnOct2), tetrahydrofuran (THF), irgacure 2959, dimethyl sulfoxide 
(DMSO), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), 4',6-
diamidino-2-phenylindole (DAPI). Dialysis tubing of 50,000 molecular weight cut off 
(MWCO) was purchased from Spectrum Laboratories.  DPSCs were obtained from Dr. 
Huang’s Lab and ADSCs were obtained from Dr. Gangaraju Rajashekar’s Lab. All the 
chemicals were used as received. Deionized distilled water was used in all the 
experiments. 
 
 
Synthesis of DEX-Lactate-HEMA and HA-AEMA Macromers 
 
DEX-Lactate-HEMA macromer with a theoretical degree of polymerization 4 
(DP) and degree of substitution 10% (DS) was synthesized according to the previously 
published procedure [4]. Briefly, at first, L-lactide (4.32 g, 0.02 mol) and HEMA (1.8 g, 
0.01 mol) were reacted in the presence of nitrogen and catalyst SnOct2 (0.05 g, 0.00013 
mol) at 110 C for 1 h. HEMA-lactate product was collected by dissolving the cooled 
reaction mixture in THF, precipitating in ice-cold water, dissolving in ethyl acetate, 
drying over MgSO4, and concentrating under reduced pressure. The yield of the above 
reaction was 35%. Next, CDI (2.59 g, 0.015 mol) was dissolved in THF (100 mL) in a 
nitrogen atmosphere and reacted with the above HEMA-lactate (4.454 g, 0.01 mol) at 
room temperature for 16 h. The resulting HEMA-lactate-imidazolyl carbamate (HEMA-
lactateCI) was obtained by solvent evaporation under reduced pressure, and the reaction 
yield was 95%. Finally, dextran (4 g, 0.024 mol of glucopyranose residues) was dissolved 
in DMSO (90 mL) in a nitrogen atmosphere. After the dissolution of DMAP (2.0 g), 
HEMA- lactate-CI (1.62 g, 0.002 mol) was added, and the mixture was stirred at room 
temperature for 4 days. The DEX-Lactate-HEMA product was obtained by precipitating 
the reaction mixture in a large excess volume of cold dry 2-propanol, washed several 
times with 2-propanol, and dried in a vacuum for at least 24 h. The yield of the final 
reaction was 85%.  
HA-AEMA macromer of molecular weight 18k and 25% AEMA substitution 
used in thesis work was synthesized by previous lab member Mr. K.B. Compton and 
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reported in his thesis [127]. 
 
 
Synthesis of P(NIPAAm-co-DEX-Lactate-HEMA) and P(NIPAAm-co-HA-AEMA) 
Hydrogels 
 
P(NIPAAm-co-DEX-Lactate-HEMA or DEX-based gels) and P(NIPAAm-co-
HA-AEMA or HA-based gels) hydrogels were synthesized by photopolymerization of 
NIPAAm monomer and hydrolytically degradable oligolactate 2-hydroxyethyl 
methacrylate (DEX-Lactate-HEMA) macromer or HA-AEMA macromer. The variables 
that were studied and optimized during the synthesis of hydrogels include: NIPAAm to 
macromer ratio, the concentration of the pre-polymer mixture, initiator concentration, UV 
intensity, reaction time, distance of the tip of the probe from the surface of the liquid, and 
dialysis time. Different weight ratios of NIPAAm:DEX-Lactate-HEMA or NIPAAm:HA-
AEMA (19:1~16:4, w:w) were used for the synthesis. Irgacure 2959, a biocompatible 
photoinitiator was used in different amounts relative to prepolymer mixture weight, 
0.0125, 0.025, 0.05 w% for the initiation of the crosslinking. Different UV intensities 
(100, 250, 375, 500, 750, 1000 mW·cm-2), and different reaction time (3, 10 min) are 
used for synthesizing the hydrogels. DEX-Lactate-HEMA (or) HA-AEMA macromers 
were dissolved in 25% ethanol. The concentration of the pre-polymer mixture used was 
0.5, 1, 2 mg·mL-1.  To the dissolved macromer solution, NIPAAm was added and 
vortexed to get a uniform solution. Initiator in different amounts (0.05, 0.025, 0.0125 
w%) were added to the above solution. 50 µL of the pre-polymer mixture was placed into 
a 96 well plate and exposed to UV at different intensities of 100-750 mW·cm-2 for 3 (or) 
10 min. The distance of the tip of the probe from the surface of a mold used was 0.5 or 0 
cm. The obtained hydrogels were dialyzed against DI water for 4-6 h with changing the 
water every half an hour in a 2 L beaker. After dialysis, the contents were collected and 
freeze-dried to get the dried polymer, and characterized by FTIR. The yield of the DEX-
based gels was 52, 75, 91 % with 0.0125, 0.025, 0.05 wt% initiator respectively and the 
yield of HA-based gels was 55, 79, 94 % with 0.0125, 0.025, 0.05 wt% initiator, 
respectively. 
 
 
Rheological Properties of the Hydrogels 
 
The rheological properties of hydrogels were tested using an AR-G2 Rheometer 
(TA Instruments, New Castle, Delaware) with 8mm parallel plate geometry. Specifically, 
the hydrogels were subjected from 0.01 to 100 percent strain, while maintaining a normal 
force to 0.01 - 0.03N, the temperature at 37°C, and a constant 1 Hz frequency of 
oscillation to determine linear viscoelastic region. 50 L of hydrogel was used in each 
run and the gap of 500 m was maintained between the top plate and bottom Peltier plate.  
The software for the rheometer was set up to take 15 sample points per decade of strain, 
for the strain sweep and 10 sample points per decade of frequency in a frequency sweep, 
and a resulting graph of the storage modulus over the range of percent strain or frequency 
was created at the termination of the procedure. Strain sweep was conducted to determine 
the linear viscoelastic region of the gels where G′ and G″ are independent of % strain. For 
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the temperature ramp, G′ and G″ were measured with an increase in temperature from 15 
to 45 C at the rate of 1 C/min.  
 
 
Sol-Gel Transition 
 
The dried DEX-Lactate-HEMA was dissolved at concentration 10 or 20 mg/mL 
in the dental pulp stem cell (DPSC) medium and transferred to Eppendorf tubes. Then the 
tubes were heated to 37C from room temperature to test the gelation.  
 
 
Cell Culture 
 
The DPSCs were cultured in DPSCs medium containing a-MEM 500 mL, FBS 55 
mL (final content: 10%-15%), 2mM L-glutamine 5.5 mL (final: 200mM), 1% antibiotics 
and 100 µg·mL-1 b-FGF 20 µL (final: 4 ng·mL-1) at 37C in a humidified incubator 
containing 5% CO2. The ADSCs were cultured in DMEM/F-12 medium containing 10% 
FBS (Fetal Bovine Serum) and 1% antibiotics. 
 
 
In Vitro Cytotoxicity of Hydrogels to Stem Cells 
 
The cytotoxicity of P(NIPAAm-co-DEX-Lactate-HEMA) and P(NIPAAm-co-
HA-AEMA) against DPSCs were performed by MTT assay. The cells were seeded in 96-
well plate at a density of 7500 cells/well. After the incubation in 150 L of DPSCs 
medium for 48 h, with replacing 100 L of medium after 24 h, the medium was replaced 
with an assigned amount of p(NIPAAm-co-DEX-Lactate-HEMA) dissolved in DPSCs 
medium, respectively, and the cells were incubated at 37 C and 5% CO2 for another 24 
h. Hydrogel solution was added to each of the test wells at different concentrations (0.5, 
1, 10 mg·mL-1).  After 24 h of incubation, 20 L of MTT solution (5 mg·mL-1 in PBS) 
was added to each well and the cells were further incubated for 4 h. A solubilizing 
solution, dimethyl sulfoxide (DMSO) is added to dissolve the insoluble purple formazan 
product into a colored solution and shaken for 10-15 minutes. The absorbance of this 
colored solution was quantified by measuring at a wavelength of 570 nm using a 
microplate reader (BioTek Instruments, Inc., Winooski, VT, USA). The relative percent 
cell viability was plotted. 
 
 
DPSCs (or) ADSCs Cell Survival Study by MTT and DAPI  
 
The materials used for this study was synthesized from macromer DEX-Lactate-
HEMA (or) HA-AEMA (18k-25), NIPAAm:macromer was used in the ratio of 19:1 
(w:w). Irgacure 2959 was used as initiator at the concentration of 0.05 w% of total 
monomer and macromer. No gap was maintained between the tip of UV probe and mold. 
UV intensity at 750 mW·cm-2 for 10 min was used. The product obtained was then 
dialyzed against 4L of distilled water for 6h by changing the water every half an hour and 
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freeze-dried. DPSCs (or) ADSCs were grown to confluence and encapsulated in 
hydrogels with cell seeding density of 5×104 cells·mL-1. Incubated at 37 °C, 5% CO2 for 
24 h. Concentrations of the hydrogels used were 10, 15 and 20 mg·mL-1. After 24 h the 
hydrogels with the cells were centrifuged and the hydrogels were replaced with the 
medium. Then the medium with cells is seeded in a 96 well plate (200 µL/well) and 24 
well plate (250 µL/well) for MTT and DAPI assays respectively and incubated at 37 °C, 
5% CO2 for 24 h. Then the following procedure was followed for the cell survival study 
by MTT. 26 μL of 5 mg·mL-1 MTT was added to each well and incubated at 37 ℃, 5% 
CO2 for 4 h. Then 200μL of DMSO was added to each well, and shaken for 15 minutes. 
The absorbance was measured at 570 nm. For the cell survival study by DAPI assay, the 
following procedure was followed. After incubation for 24 h at 37 °C, 5% CO2, the cells 
were washed with PBS 2-3 times and fixed by using 4% paraformaldehyde for 15 min. 
Then the cells were washed with PBS for 2-3 times and incubated with DAPI at 
concentration 1µg·mL-1 for 15 - 20 min. After incubation, the cells were again washed 
with PBS for 2-3 times and then the images were taken at 10x. 
 
 
Statistical Analysis 
 
Data were reported as the mean ± standard deviation (SD) or mean ± standard 
error (SE) from at least n=3. Two-tailed Student’s t-test was used to analyze the 
differences between groups. A statistically significant difference was reported if p=0.05 
or less. 
 
 
Results and Discussion 
 
 
Synthesis and Characterization of Hydrogels 
 
UV initiated photo emulsion polymerization, using Irgacure 2959 as an initiator, 
offered the flexibility of fabricating the hydrogels under mild conditions such as low 
temperature (room temperature) and short reaction times (<10 mins). Also, the initiator 
Irgacure 2959 solution has been widely used for in situ polymerization in vivo and does 
not cause irritation [128]. The synthesis was successful and confirmed by FTIR spectra of 
hydrogels 19:1 - NIPAAm to macromer are shown in Figure 2-1. The hydrogels contain 
characteristic peaks from both PNIPAAm and DEX-Lactate-HEMA or HA-AEMA 
macromer, namely, the absorbance of the carbonyl group at 1640 cm-1, N-H bending at 
1538 cm-1 and N-H stretching at 3300 cm-1 are the characteristic peaks of NIPAAm. The 
divided bands of symmetric C-H bending from the -CH(CH3)2 group (1369 and 1367 cm
-
1) are attributed to PNIPAAm, C-OH stretching (∼1020 cm-1) due to the abundant 
hydroxyl groups of dextran backbone and C-H asymmetric stretching at 2974 cm-1. All 
the OH and NH stretching were confined b/w 3000 -3500 cm-1. The presence of more 
hydroxyl groups in dextran gives rise to the high-intensity peaks in the spectrum of DEX-
Lac-HEMA.  
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Figure 2-1. FTIR spectrum of hydrogels 
 
Notes: N-H stretching at 3287 cm-1, C-H asymmetric stretching at 2974 cm-1, absorbance 
of amide-carbonyl group at 1640 cm-1, N-H bending at 1538 cm-1, symmetric C-H 
bending from the -CH(CH3)2 group at 1367 cm
-1 and C-OH stretching at 1021 cm-1 
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The early stage of optimization of the variables was primarily focused on 
P(NIPAAm-co-DEX-Lactate-HEMA) hydrogels. The endpoints or the observations that 
were monitored during the synthesis optimization include: i) State or physical appearance 
of the reaction mixture after photopolymerization if it is a liquid or solid gel, ii) State or 
physical appearance of the reaction mixture after heating at 37°C. The ideal 
characteristics of the gel include: being liquid at room temperature and turning into 
solid/gel upon heating to 37°C. The observations/comparisons of the formation of gels 
with the changes in parameters and the trends are mentioned in Table 2-1. When the 
DEX-Lactate-HEMA macromer concentration was increased from 5 to 20%, strong 
insoluble gels were formed, and this could be attributed to higher crosslinking in case of 
16:4 hydrogels compared to 19:1.  
 
The polymerization is proportional to the monomer concentration and inversely 
related to the initiator concentration. The higher the concentration of the polymer, 
stronger the polymer with higher molecular weight and more insoluble it could become. 
Similar results were observed when the prepolymer mixture concentration was increased, 
the gelation increased and the gel becomes more insoluble and resulted in a solid gel. 
However, the gels formed at 1mg·mL-1 concentration showed favorable results as they 
exhibited viscous liquid behavior and turned solid upon heating. Table 2-1 also presents 
the gelation process of the hydrogels with an increase in the initiator concentration as 
well. The size of the solid gels formed was same for 0.05 and 0.025 irgacure w% but it 
decreased with the 0.0125 irgacure w%, however, the yield was less with the decrease in 
the initiator concentration to 0.025 and 0.0125 wt%. Overall, with the decrease in the 
initiator (irgacure), the size of the solid gels obtained decreased and this could be 
attributed to the formation of insoluble higher chain length polymer at higher initiator 
concentration. The optimum concentration was found to be 0.05 w%.  Based on the 
results from Table 2-1, it can also be observed that the gelation process increased with 
increase in UV intensity. 500 mW·cm-2 was selected and continued to characterize 
further.  
 
In vitro cytotoxicity testing of the P(NIPAAm-co-DEX-Lactate-HEMA) gels 
(synthesized at 1 mg·mL-1, 500 mW·cm-2, 0.5 cm distance. 3 min reaction time) showed 
toxicity and had low percentage cell viability values (below 50%). In case of 19:1, the 
gels made at 0.0125 wt% initiator showed higher cytotoxicity (1.6 fold) than gels made at 
0.05 and 0.025 wt% initiator. However, 16:4 gels showed a different behavior where the 
gels made at 0.05 and 0.0125 wt% were toxic than that of gels made at 0.025 wt%. 
Overall, all the gels were cytotoxic to the DPSCs, which could be attributed to lack of 
complete polymerization of the monomer/macromer mixture, and presence of any 
unreacted monomer/macromers that were toxic to the cells. In order to complete the 
polymerization, the reaction time (time of UV exposure) was increased from 3 to 10 min. 
and the resulted polymeric gels were compared with raw materials (PNIPAAm and DEX-
Lactate-HEMA macromer) in terms of cytotoxicity to DPSCs. The raw materials were 
found to be toxic (%cell viabilities 40-80) to the DPSCs at all the studied concentrations 
0.1, 10, 20 mg·mL-1. However, after polymerization P(NIPAAm-co-DEX-Lactate-
HEMA) gels were found to be non-toxic at 0.1 mg·mL-1 concentration, still, the cell  
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Table 2-1. Effect of NIPAAM/DEX-Lactate-HEMA macromer ratio, UV 
intensity, precursor concentration, initiator concentration on the formation of 
P(NIPAAM-co-DEX-Lactate-HEMA) gels. 
 
 
Notes: Macromer* : DEX: DEX-Lactate-HEMA; HA: HA-AEMA; NIPAAm : 
Macromer = 19:1 (or) 16:4 (w:w), Concentration : 0.5,1,2 mg·mL-1; UV intensity : 100, 
250, 375, 500, 750, 1000 mW/cm2 Distance between tip of the UV probe and mold : 0, 
0.5 cm 
  
Precursor 
concentration 
(mg/µL) 
UV 
intensity 
(mW·cm-2) 
Macromer* NIPAAm/        
macromer 
(w/w) 
Irgacure 
(w%) 
Distance between 
tip of UV probe 
and surface of 
liquid (cm) 
Product appearance 
1 100 DEX 19:1 0.05 0.5 Liquid 
1 250 DEX 19:1 0.05 0.5 Liquid 
1 375 DEX 19:1 0.0125 0.5 Liquid + small soft 
gel 
1 375 DEX 19:1 0.025 0.5 Liquid + soft gel 
0.5 375 DEX 19:1 0.05 0.5 Soft gel 
1 375 DEX 19:1 0.05 0.5 Liquid + soft gel 
2 375 DEX 19:1 0.05 0.5 Soft gel 
1 500 DEX 19:1 0.05 0 Soft gel 
1 250 DEX 16:4 0.05 0.5 Liquid 
1 375 DEX 16:4 0.0125 0.5 Liquid + small soft 
gel 
1 375 DEX 16:4 0.025 0.5 Liquid + soft gel 
0.5 375 DEX 16:4 0.05 0.5 Soft gel 
1 375 DEX 16:4 0.05 0.5 Liquid 
2 375 DEX 16:4 0.05 0.5 Soft gel 
1 500 DEX 16:4 0.05 0.5 Soft gel 
1 750 DEX 19:1 0.05 0 Soft gel 
1 750 DEX 19:1 0.05 0 Soft gel 
1 750 HA 19:1 0.05 0 Soft gel 
1 750 HA 19:1 0.05 0 Soft gel 
1 750 HA 19:1 0.05 0 Soft gel 
1 1000 DEX 19:1 0.05 0 Strong soft gel 
1 1000 DEX 19:1 0.05 0 Strong soft gel 
1 1000 DEX 19:1 0.05 0 Strong soft gel 
1 1000 HA 19:1 0.05 0 Strong soft gel 
1 1000 HA 19:1 0.05 0 Strong soft gel 
1 1000 HA 19:1 0.05 0 Strong soft gel 
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viability values decreased with increased polymer concentration. Increasing the reaction 
time alone did not result in reduced cytotoxicity of the hydrogels. The synthetic 
conditions used might have resulted in partial or incomplete polymerization and presence 
of any unreacted starting materials, because of these the gels were found to be toxic. 
Therefore, the gel synthesis parameters needed more optimization.  
 
To further optimize the gels to improve the polymerization and to lower the 
cytotoxicity, the variables that are altered during the synthesis include i) distance between 
the UV probe and the tip of the liquid surface. Instead of using 0.5 cm distance, the gap 
between the UV probe and the mold surface was completely eliminated and kept at 0 cm 
distance; ii) the UV intensity was increased from 500 mW·cm-2 to 750 mW·cm-2; and iii) 
the dialysis time was increased from 4 h to 6 h to remove any unreacted raw materials. 
The gels obtained were exposed to DPSCs to estimate the in vitro cytotoxicity. Figure  
2-2 illustrates the cell viability of gels (synthesized at different initiator levels) to DPSCs 
at three different concentrations 0.5, 1 and 10 mg·mL-1. Independent of the initiator 
percentages (0.05, 0.025, 0.0125 wt%) used in the synthesis, elimination of gap, increase 
in UV intensity and dialysis time had shown a drastic improvement in the cell viability 
values of the gels. The cell viabilities improved from 40-60% to 90-100%. Removing the 
gap and increasing the UV intensity might have increased the polymerization, and 
increasing the dialysis time might have led to the removal of any unreacted starting 
materials, and this could have resulted in the improved cell viability of the gels. Overall, 
the gels made with 0.05 w% initiator concentration has shown relatively higher yield 
when compared with the 0.025 and 0.0125 w%. Increased initiator concentration could 
lead to higher polymer chain length and as result, the hydrogels with 0.05 w% initiator 
concentration could have formed the gels with higher yield when compared with lower 
initiator concentration. 
 
Synthesis and Comparison of Hydrogels Based on HA-AEMA Macromer 
 
After optimizing the synthetic parameters of the injectable hydrogels, another 
macromer based on hyaluronic acid was investigated for synthesizing the hydrogels and 
compared the properties with dextran-based hydrogels.  The P(NIPAAm-co-HA-AEMA) 
hydrogels were synthesized at NIPAAm/Macromer of 19:1 (w:w) with prepolymer 
concentration of 1 mg·mL-1 by direct exposure to UV probe (without gap) at two different 
intensities (750 and 1000 mW·cm-2) and three different initiator concentrations (0.05, 
0.025, 0.0125 w%). The gels synthesized were observed for their physical appearance 
and compared with P(NIPAAm-co-DEX-Lactate-HEMA). The observations are 
mentioned in Table 2-1.  When observed for the overall trend, both the gels formed at 
higher intensity resulted in a stronger solid gel formation before dialysis. However, all 
the gels (polymerization mixture) after dialysis yielded a viscous gel. No other significant 
differences were found in terms of the physical appearance of the gels. 
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Figure 2-2. Cell viability of the P(NIPAAM-co-DEX-LactateHEMA) gels to 
DPSCs. 
 
Notes: Macromer: DEX: DEX-Lactate-HEMA; NIPAAm: Macromer = 19:1 (w:w), 
Concentration : 1mg·mL-1; UV intensity : 500, 750 mW/cm2; Distance between tip of the 
UV probe and mold : 0 cm. 
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Rheological Properties 
 
The rheological property of hydrogels needs to be evaluated for their rheological 
behavior within their range of linear viscoelastic region to ensure their stability [129]. 
Figure 2-3 illustrates the linear viscoelastic region of the P(NIPAAm-co-DEX-Lactate-
HEMA) and P(NIPAAm-co-HA-AEMA) gels under oscillatory strain ramp. The G′ of 
hydrogels remains unaffected by strain amplitude (linear viscoelastic region) for 2 – 20% 
and 2-100% (Figure 1-3) for every Dextran-based and HA-based gels respectively. The 
gels exhibited similar behavior at both 10 and 15 mg·mL-1 concentrations. In case of 
strain sweep, when the concentration of the hydrogels was increased from 10 to 15 
mg·mL-1, the G′ was increased about 2.4 fold for dextran-based hydrogels and 3.2 fold 
for HA-based hydrogels. At 15 mg·mL-1, the value of G´ at 1 Hz appears in the range of 
20-40 Pa for HA-based gels and 15-35 Pa for dextran-based gels. Since both the 
hydrogels have shown linear viscoelasticity at 10% strain, in order to ensure that 
measurements are done within the linear viscoelastic region, all subsequent rheological 
characterization was performed at 10% strain. Frequency sweep studies were conducted 
to determine the characteristic gel behavior (G′>G″). Figure 2-4 shows the G′ and G″ of 
the hydrogels as a function of frequency. The G′ was always higher than G″ suggesting 
that the elastic behavior dominates the viscous behavior in these hydrogels, which is the 
typical characteristic of a hydrogel. After about 2 Hz frequency, both the G′ and G″ 
increased linearly with increasing frequency, suggesting that both types of hydrogels 
were in the glass transition stage and became stiffer with increasing frequency. In case of 
HA-or Dextran-based hydrogels, increase in concentration from 10 to 15 mg·mL-1 has 
resulted in a significant increase in G′ and G″ values (2-4 fold). No significant differences 
were found for the hydrogels prepared with the HA or dextran at the same concentration, 
as the majority of the polymer is NIPAAm (95%). The individual figures of strain sweep, 
frequency sweep and temperature ramp for each hydrogel are given in the Appendix 
(Figure A-1 through Figure A-12). 
 
 
Sol-Gel Transition of Hydrogels  
 
The feasibility of P(NIPAAm-co-DEX-Lactate-HEMA) hydrogels for using as 
injectable in situ hydrogels for tissue engineering, a sol-gel transition study was 
conducted to evaluate their behavior in presence of stem cells. The solutions of gels (10 
mg/mL and 20 mg·mL-1) encapsulated with DPSCs were immediately transformed 
(gelation time <2 min) into solid gels when exposed to 37°C (Figure 2-5). The 
temperature-dependent transition of hydrogels was studied by monitoring the storage 
modulus values as a function of temperature on a rheometer. Followed by a plateau 
regime, rapid buildup regime was observed in G′ (Figure 2-6), and this fast increase in G′ 
was attributable to gelling (sol to gel transition) or 3D crosslink network formation of the 
polymeric chains. Because of the strong hydrophobic interactions between the PNIPAAm 
chains above LCST, the PNIPAAm exhibit a phase transition or thermoresponsive 
behavior. The midpoint temperature (~35 °C) of the transition is about the same for all 
samples. 
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Figure 2-3. Representative shear storage modulus (G′) and shear loss modulus 
(G″) as a function of oscillatory strain sweep for the hydrogels. 
 
 
 
 
 
 
Figure 2-4. Representative shear storage modulus (G′) and shear loss modulus 
(G″) as a function of frequency for the hydrogels. 
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Figure 2-5. The thermoresponsive sol-gel transition of the hydrogels. 
 
 
 
 
 
 
Figure 2-6. Thermoresponsive phase transition and representative change in 
shear storage modulus (G′) and shear loss modulus (G″) as a function of 
temperature ramp for the hydrogels. 
  
 23 
Cell Survival in Hydrogels 
 
To assess the cytotoxicity of DPSCs and ADSCs encapsulated in Dex and HA-
based hydrogels in vitro, the MTT assay was utilized. The DPSCs & ADSCs viability in 
Dex-based hydrogels with a concentration of 10, 15, 20 mg·mL-1 was about 117±7.4, 
106±7.8, 79±5.3 & 110±7.8, 99±6.6, 80±7.3 % respectively (Figure 2-7). The DPSCs & 
ADSCs viability in HA-based hydrogels with a concentration of 10, 15, 20 mg·mL-1 was 
about 122±6.6, 103±12.8, 91±7.1 & 143±9.7, 132±9.1, 90±9.4 % respectively (Figure  
2-8). There was a statistically significant decrease in the cell viability for the Dex-based 
hydrogels between concentrations of 10 and 15, 15 and 20 mg/mL for the ADSCs 
(p<0.05). DPSCs cell viabilities in Dex-based hydrogels decreased significantly between 
15 and 20 mg/mL (p<0.01). In HA-based hydrogels the ADSC viabilities decreased 
significantly between the concentrations 10 and 15 (p<0.05), 15 and 20 mg/mL (p<0.01).  
In addition to the cell viability by MTT, the percentage live cell number of the DPSCs 
and ADSCs after 24hrs of encapsulation in the hydrogels was determined using DAPI 
(Figure 2-9 and Figure 2-10). The DPSCs & ADSCs percent cell number compared to 
control in Dex-based hydrogels with a concentration of 10, 15, 20 mg·mL-1 was about 
112±1.58, 102±1.22, 80±0.71 & 121±2.92, 97±1.41, 89±0.71 % respectively (Figure  
2-11). The DPSCs & ADSCs percent cell number in HA-based hydrogels with a 
concentration of 10, 15, 20 mg·mL-1 was about 127±3.39, 107±0.71, 82±1.22 & 
134±3.67, 97±0.71, 89±1.87 % respectively (Figure 2-12). There was a statistically 
significant decrease in the ADSCs number for the Dex-based hydrogels between 10 & 15, 
15 & 20 mg/mL (p<0.01). In Dex and HA-based hydrogels the DPSCs number decreased 
significantly between the concentrations 10 and 15 (p<0.05), 15 and 20 mg/mL (p<0.01). 
In HA-based hydrogels the ADSC viabilities decreased significantly between 10 and 15 
mg/mL (p<0.01). Cell survival studies based on MTT and DAPI live cell counting 
demonstrated that both DEX-based and HA-based based hydrogels showed promising 
cell viability and cell number values (~100% and above) at concentrations of 10 and 15 
mg/mL for DPSCs and ADSCs. The results from the MTT assay and cell number studies 
by DAPI staining were in accordance with each other and confirm that the Dex & HA 
hydrogels are suitable for the encapsulation of ASDSCs & DPSCs at 10 and 15 mg/ml 
concentrations.  
 
 
Conclusions 
 
A series of biodegradable hydrogels were synthesized by photopolymerization of 
NIPAAm monomer and hydrolytically degradable oligolactate DEX-Lactate-HEMA or 
HA-AEMA macromers. The thermoresponsive, rheological and biodegradable properties 
of the hydrogels were strongly dependent on the reaction conditions and composition of 
the hydrogels. The higher the amount of the Irgacure 2959 initiator, the higher the UV 
intensity, the longer the reaction time, and the higher amounts of crosslinker used for the 
synthesis, the higher the yield of the synthesized hydrogels. The hydrogels were not 
cytotoxic to DPSCs and ADSCs at a concentration up to at least 15 mg·mL-1, and have 
appropriate mechanical and biodegradable properties to promote DPSCs and ADSCs 
growth. Based on in vitro studies it was observed that DEX-gels and HA-gels appear to   
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Figure 2-7. Cell viability of DPSCs & ADSCs in injectable NIPAAm-DEX-
Lactate-HEMA hydrogels using MTT assay. 
 
Notes: NIPAAm:DEX-Lactate-HEMA - 19:1, Initiator – 0.05%, UV - 750mW·cm-2, UV 
exposure time - 10 min, Distance of UV probe from the mold – 0 cm. (Mean ± SD, n=3; *: 
p-value < 0.05, #: p-value < 0.01) 
 
 
 
 
 
 
Figure 2-8. Cell viability of DPSCs & ADSCs in injectable NIPAAm-HA-AEMA 
hydrogels using MTT assay. 
 
Notes: NIPAAm:HA-AEMA - 19:1, Initiator – 0.05%, UV -750mW·cm-2, UV exposure 
time - 10 min, Distance of UV probe from the mold – 0 cm. (Mean ± SD, n=3; *: p-value 
< 0.05, #: p-value < 0.01) 
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Figure 2-9. DPSCs growth and morphology in injectable P(NIPAAm-co-DEX-
Lactate-HEMA ) and P(NIPAAm-co-HA-AEMA) hydrogels. 
 
Notes: P(NIPAAm-co-DEX-Lactate-HEMA) – represented as DEX in Figure (Synthetic 
conditions: NIPAAm:DEX-Lactate-HEMA-19:1, Initiator – 0.05%, UV – 750 mW·cm-2, 
UV exposure time - 10 min, Distance of UV probe from the mold – 0 cm; Cells staining – 
DAPI);  
P(NIPAAm-co-HA-AEMA) – represented as HA in Figure (NIPAAm:HA-AEMA-19:1, 
Initiator – 0.05%, UV – 750 mW·cm-2, UV exposure time - 10 min, Distance of UV 
probe from the mold - 0cm; Cells staining – DAPI) 
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Figure 2-10. ADSCs growth and morphology in injectable P(NIPAAm-co-DEX-
Lactate-HEMA) and P(NIPAAm-co-HA-AEMA) hydrogels. 
 
Notes: P(NIPAAm-co-DEX-Lactate-HEMA) – represented as DEX in Figure (Synthetic 
conditions: NIPAAm:DEX-Lactate-HEMA-19:1, Initiator – 0.05%, UV – 750 mW·cm-2, 
UV exposure time - 10 min, Distance of UV probe from the mold - 0cm; Cells staining – 
DAPI); 
P(NIPAAm-co-HA-AEMA) – represented as HA in Figure (NIPAAm:HA-AEMA-19:1, 
Initiator – 0.05%, UV – 750 mW·cm-2, UV exposure time - 10 min, Distance of UV 
probe from the mold - 0cm; Cells staining – DAPI) 
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Figure 2-11. Cell count of DPSCs & ADSCs in injectable NIPAAm-DEX-Lactate-
HEMA hydrogels by DAPI staining. 
 
Notes: NIPAAm: DEX-Lactate-HEMA - 19:1, Initiator – 0.05%, UV – 750mW·cm-2, UV 
exposure time - 10 min, Distance of UV probe from the mold – 0 cm. (Mean ± SD, n=4; 
*: p-value < 0.05, #: p-value < 0.01) 
 
 
 
 
 
 
Figure 2-12. Cell count of DPSCs & ADSCs in Injectable NIPAAm-HA-AEMA 
Hydrogels by DAPI staining. 
 
Notes: NIPAAm: HA-AEMA - 19:1, Initiator – 0.05%, UV – 750mW·cm-2, UV exposure 
time - 10 min, Distance of UV probe from the mold – 0 cm. (Mean ± SD, n=4; *: p-value 
< 0.05, #: p-value < 0.01) 
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be suitable for encapsulation of DPSCs/ADSCs at optimum hydrogel concentration. The 
data confirmed that both DPSCs and ADSCs favorably adhered and proliferated within 
the biomaterials in vitro. Additionally, the current study confirmed that DPSCs and 
ADSCs have superior growth properties in HA-AEMA hydrogels compared to DEX-
Lactate-HEMA hydrogels. The developed hydrogels have shown promising potential for 
encpaulsating DPSCs/ADSCs for tissue engineering aplications. However, further 
optimization is needed to have apropriate mechanical and degradation properties to cater 
as per DPSCs or ADSCs growth inside their matrices, and successful completion of this 
project will have a significant impact on dental and retinal tissue engineering fields. 
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CHAPTER 3.    RHEOLOGICAL PROPERTIES OF THE PORCINE OCULAR 
TISSUES AT DIFFERENT STAGES OF DEVELOPMENT 
 
 
Introduction 
 
The eye is a complex and delicate organ being divided into two anatomical 
segments called the anterior (comprises of cornea, conjunctiva, iris, lens, ciliary body, 
and the anterior part of the sclera) and posterior (comprises of vitreous humor, retina, 
choroid, and posterior part of the sclera) segments [130]. Cornea, sclera and vitreous 
humor are the three tissues that were investigated in this study for the rheological 
properties.  The cornea is a specialized transparent tough tissue covering the front portion 
of the eye and protects the sensitive internal contents of the eye and is responsible for 
refracting the light [131].  The tissue is under constant stress because of various forces 
such as external (eye rubbing, poking, eyelid closure) and internal (intraocular pressure 
because of aqueous/vitreous flow dynamics). Cornea’s mechanical behavior, fundamental 
for maintaining its dimensional stability, refractability and vision, depends on the 
thickens, topography and biomechanical properties of the tissue [28]. The extracellular 
matrix of the cornea called the stroma forming the bulk of the corneal thickness primarily 
contributes to its biomechanical properties [131]. The sclera is a dense connective tissue 
covering the five-sixths of the eye. The sclera is a strong and firm tissue and maintains 
the shape of the globe. It helps in the maintenance of intraocular pressure, provides 
attachment sites for the external eye muscles, and provides the internal eye structures 
from injuries and mechanical displacement. The vitreous body/vitreous humor is a 
transparent and gelatinous substance that fills the inner posterior cavity (space between 
the lens and the retina) of the eye. Vitreous humor is highly hydrated and comprised of 
99% of water, avascular, and nearly acellular. The unique extracellular matrix of the 
vitreous humor, composed of a complex network of collagen fibers and hyaluronic acid 
(glycosaminoglycan), significantly contributes to the viscoelastic nature of the vitreous 
[132]. Vitreous plays a significant role in metabolic nutrient supply to the lens, 
coordinating eye growth (developmental) allows light to reach the retina (optical), 
providing support to the retina, maintain the shape of the eyeball and protects eye tissues 
from high-frequency stresses (mechanical) [132, 133].  
 
The proper vision of the eye strongly depends on its ability to maintain optical 
clarity and structural integrity under routine variations in pressure, changes in humidity 
and temperature, constant muscular stress/strain and rapid sudden movements. Thus the 
proper functioning of the eye is dependent on its physical and mechanical properties, and 
altered chemical and mechanical states of ocular tissues could lead to abnormalities and 
may result in complete loss of the functionality. Various age-related changes in 
composition and structure of the eye tissues affect the biomechanical properties and 
performance of the eye tissues and could contribute to the predisposition of various eye 
abnormalities [21-26]. For example, aging results in stiffening of the cornea tissue which 
could be because of the additional age-related non-enzymatic cross-linking affecting the 
stromal collagen fibrils [24, 25]. It is reported in the literature that age-related variations 
affect the biomechanical characteristics of the sclera [21], and aging results in the 
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microstructural changes in the sclera and contribute to the predisposition to primary 
open-angle glaucoma [22].  With age, collagen networks in the vitreous begin to break 
down and pockets of liquid form in the eye, the process of liquefaction in which the 
liquid volume increases and gel volume decreases [23, 26]. These age-related changes 
could lead to structural and mechanical differences between vitreous at various stages of 
development, and in about 25-30% of the population, these age-related degenerative 
changes eventually result in posterior vitreous detachment [27]. Given the importance of 
the viscoelastic properties of the ocular tissues, to its function and to pathology, detailed 
rheological characterization of these tissues is crucial to appreciate the normal functions 
and quantitative understanding of disease pathophysiology of these tissues at various 
stages of development. The objective of this project was to characterize the rheological 
properties of the ocular tissues (cornea, sclera and vitreous) at different stages (preterm, 
neonatal and adult) of development. Though several measurements could be measured in 
vivo, such as topography, thickness distribution, but the attempts to investigate the 
biomechanical properties of the tissues still depend on ex-vivo experiments involving 
human or other animal tissues [28]. Because of the difficulties in obtaining human donor 
tissues in sufficient numbers for the research and experimental needs, it had been 
necessary to use animal ocular tissues as approximate models for human ocular tissues 
for performing various evaluations including the mechanical property characterization 
studies. Several investigations used porcine tissues for ocular related experiments [28-
30], although other animal’s rabbit and bovine tissues a common practice. Therefore, the 
current rheological characterization also contributes to the literature for identifying and 
assessing the important similarities and significant differences between the rheological 
behaviors of porcine ocular tissues and human and other animal tissues and evaluating 
the suitability of the porcine eye tissues as a model of the human tissues.  
 
 
Hypothesis and Specific Aims 
 
The hypothesis of this project was that the storage and loss modulus of the 
porcine ocular tissues differ at different stages of development (preterm, neonatal and 
adult). There were two specific aims: 
 
 
Specific Aim 1  
 
To conduct the shear-sweep experiments and identify the linear viscoelastic 
region of the porcine ocular tissues (cornea, sclera, vitreous) at different stages of 
development (preterm, neonatal, adult). 
 
 
Specific Aim 2 
 
To conduct the frequency sweep experiment and analyze the gel-like behaviors of 
the porcine ocular tissues (cornea, sclera, vitreous) at different stages of development 
(preterm, neonatal, adult). 
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Materials and Methods 
 
 
Materials 
 
 Sodium Chloride (NaCl), potassium chloride (KCl), calcium chloride (CaCl2), 
magnesium chloride (MgCl2), sodium dihydrogen phosphate (NaH2PO4), sodium 
bicarbonate (NaHCO3), sodium hydroxide (NaOH) and Hydrochloric acid (HCl) were 
bought from Sigma Aldrich. Porcine eyes tissues were obtained from Dr. Steven Davison 
and Dr. Cameron Fili.  
 
 
Sample Preparation 
 
Fresh porcine eyeball tissues were provided by Dr. Steven Davison and Dr. 
Cameron Fili.  A circular trephine punch from Katena was used to punch specimens of 
diameter 8 mm from the central region of the cornea and from the region below optic 
nerve in the sclera. AR-G2 TA Instruments Rheometer with accompanying Rheology 
Advantage Instrument Control software was used to perform the experiments. Prior to 
testing, the specimens were equilibrated in GBR solution (bicarbonate-Ringer's solution 
(BR) containing reduced glutathione) (NaCl, 6.2 g/L; KCl, 0.358 g/L; CaCl2, 0.115 g/L; 
MgCl2, 0.159 g/L; NaH2PO4, 0.103 g/L; NaHCO3, 2.454 g/L; glucose, 0.90 g/L; reduced 
glutathione, 0.92 gm./L and pH was adjusted to 7.4 using Sodium hydroxide (NaOH) and 
Hydrochloric acid (HCl) [134], which has been shown to maintain endothelial function 
for up to 6 hr., was added to the immersion cell bathing either side of the cornea tissue. 
The thickness of the specimens was measured using screw gauge. The sample was placed 
on the lower geometry, and then the upper geometry was lowered to contact the sclera. 
The gap between the parallel plates was maintained at the thickness of the sample tissues 
used and the experiments were done. In this experimental method, circular specimens of 
sclera and cornea tissues are sheared between two parallel plates. In order to characterize 
the shear viscoelastic properties, two types of oscillatory tests, i.e. the strain and 
frequency sweep experiments, were conducted. Although, it is known that the cornea and 
sclera tissues have an inhomogeneous microstructure through the thickness, and the 
present study did not consider these inhomogeneities and its findings should only be 
considered as the macroscale (effective) shear properties of the tissue. However, care was 
taken while sample preparation to be consistent. For characterizing the range of linear 
viscoelasticity, the strain sweep experiments (4 samples) were done at frequency 1Hz and 
force 0.01 N. For frequency sweep experiments (4 samples), the frequency of 0.01–100 
Hz and a shear strain magnitude of 0.05 % (which was within the region of linear 
viscoelasticity) were selected. The age and weight of pigs are mentioned in Table 3-1. 
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Table 3-1. Age and weight of pigs used in the study. 
 
Pig Age Weight 
Preterm Pig 10 days prior 0.5 -1.5 Kg 
Neonatal Pig 20 days 2.5 - 3.5 Kg 
Adult Pig 1 year 80 - 100 Kg 
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Rheological Properties 
 
Strain sweep oscillation was performed to determine the limit of linear 
viscoelasticity. Four preconditioned specimens were tested at 1 Hz frequency. For the 
determination of linear viscoelastic region (where G′ and G″ remain constant), strain 
sweep oscillation was performed at constant frequency with varying strain amplitude 
from 0.01 to 100%. Unlike the conventional solid mechanical definition, strain here is 
defined as the excursion of the circumference of the disk-shaped specimen divided by its 
thickness. Rheological properties such as G′ and G″ remain constant within the limit of 
linear viscoelasticity. After the determination of tissue’s viscoelastic region by a strain 
sweep, the tissues were further characterized by a frequency sweep at a strain in the linear 
viscoelastic region to understand the gel behaviors of the tissues (G′>G″). The viscosity 
of the whole vitreous was measured at a shear rate 0.1 to 1000 s-1 under continuous flow 
mode. 
 
 
Results and Discussion 
 
Figures 3-1, 3-2 and 3-3 show the range of linear viscoelasticity of the porcine 
cornea, sclera and vitreous as a function of strain sweep (at 1 Hz frequency) at different 
ages. These figures confirm that the studied tissues, like other soft tissues, showed a 
viscoelastic behavior. The strain sweep experiments on all the tissues at different ages 
showed that the measured storage modulus was nearly constant over small amplitude 
shear strain (%) and decreased nonlinearly with increasing percent strain after a turnover 
point, called critical shear strain level. Two different regions were clearly differentiated: a 
linear viscoelastic region where  G′ and G″ were practically constant (small deformation), 
and a nonlinear region, in which G′ and G″ began to diminish with increasing strain 
(large deformations) [135]. Within the range of linear viscoelastic response, the 
viscoelastic parameters are independent of the shear strain amplitude. The strain 
independent region indicates that extent of strain applied is small enough not to cause any 
perturbance in the structure of the material, and in biological samples, these linear region 
includes normal physiological loads and represent normal in vivo response [136]. The 
individual figures of strain sweep, frequency sweep and viscosity for each tissue or 
vitreous are given in the Appendix (Figure A-13 through Figure A-33). 
 
In the linear viscoelastic region (Figure 3-1), the values of G′ and G″ for all 
corneal tissues were constant below 2% strain and decreased logarithmically with 
increasing strain (>2% strain). Linear region for the corneal samples was found to be 0.01 
– 2% strain. The consistent linear regions of both G′ and G″ were observed for all the 
corneal samples at different ages. Similar to the cornea, scleral tissues (Figure 3-2) also 
behaved as gel-like and exhibited linear viscoelastic region below 3% strain in preterm 
and neonatal, and 0.1% strain in adult pigs, the critical strain related to the linear 
viscoelastic region in sclera tissues was different at different ages. Vitreous also exhibited 
gel-like behavior with a linear viscoelastic region (Figure 3-3). It was reported that the 
gel-like physical properties of vitreous are primarily derived from its chemical 
composition which includes a hydrated cross-linked network of fibrillar collagens (type)   
 34 
 
 
Figure 3-1. Storage and loss moduli of corneal tissues at preterm, neonatal and 
adult stages of development under strain-sweep. 
 
 
 
 
 
 
Figure 3-2, Storage and loss moduli of scleral tissues at preterm, neonatal and 
adult stages of development under strain-sweep. 
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Figure 3-3. Storage and Loss moduli of vitreous humor at preterm, neonatal and 
adult stages of development under strain-sweep. 
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and higher-molecular-weight polyanionic hyaluronan macromolecules, which is 
consistent with the literature [137]. 
 
Once the range of linear viscoelastic region was determined, frequency sweep 
experiments were performed on the samples with a strain amplitude that was within the 
range of linearity for each sample (Figures 3-4, 3-5 and 3-6). In corneal samples, the 
moduli increased weakly with increasing frequency (Figure 2-2a), and this trend was 
similar to the response of corneal stroma [131]. This behavior also related to other tissues 
such as articular cartilage, meniscus, and intervertebral disk [131, 138-140]. The 
magnitude of change (increase in storage modulus) increased significantly at a higher 
frequency (>5 Hz). Adult cornea tissue has shown higher G′ and G″ compared to the 
preterm and neonatal corneal tissues. At 1 Hz frequency, the G′ values of preterm, 
neonatal and adult cornea were ~0.89, 0.97 and 1.22 kPa, respectively. Similar to the 
cornea, scleral tissues (Figure 3-5) also showed a slight increase in moduli with an 
increase in the frequency in the low-frequency range (<10 Hz), and the magnitude of 
increase in the moduli changed significantly at a higher frequency (>10 Hz). The moduli 
values of sclera increased with increase in the age (preterm<neonatal<adult). At 1 Hz 
frequency, the G′ values of preterm, neonatal and adult sclera were ~0.96, 1.81 and 16.8 
kPa, respectively. In frequency dependence studies, the storage modulus of vitreous 
varied weakly with frequency up to ~0.4 Hz (Figure 3-6) and raised significantly 
thereafter. This frequency dependence behavior is characteristic of a lightly crosslinked 
amorphous network of macromolecules and is consistent with the literature [136]. The 
storage modulus of the adult vitreous was higher at low frequency (<0.2 Hz) but were 
similar thereafter to neonatal and preterm samples. At 1 Hz frequency, the G′ values of 
preterm, neonatal and adult vitreous were ~4.5, 4.8 and 8.8 Pa, respectively. 
 
In frequency dependence studies, all three types of tissues showed a similar 
behavior of weak variation in moduli with increased frequency. Also, it can be observed 
that irrespective of the age, all tissue samples showed G′ > G″, which represents that 
elastic properties of the materials dominate the viscous portion and the samples exhibited 
solid-like behavior. The difference between G′ and G″ of corneal and scleral samples is 
much higher compared to the vitreous humor, and the magnitude of G′/ G″ among the 
tissues was in the order of cornea > sclera >> vitreous. Thus, the cornea and sclera are 
more gel-like than the vitreous humor, as the elastic character of the tissue is manifested 
in the storage modulus.  
 
When the vitreous was ran under shear rate-controlled experiments (Figure 3-7), 
the viscosity of the vitreous decreased with increasing shear-rate exhibiting a shear-
thinning behavior (non-Newtonian) with a value around 39.5±2.7, 40.3±9.1, 54.8±1.2 for 
a share rate of 0.93 s-1 and reaching a value around 3.2±0.1, 3.4±0.8, 4.1±0.1 for shear 
rate of 100 s-1 for preterm, neonatal, and adult porcine vitreous, respectively. At low 
shear rates (~1 s-1), the viscosity of the adult vitreous was significantly higher than the 
neonatal and preterm porcine vitreous. The shear-thinning behavior of the vitreous was 
consistent with the literature [141]. It is reported that this behavior could be attributed to 
the presence of HA (primary component) in the liquid portion of the vitreous [141]. HA 
solutions exhibit this shear thinning behavior [142]. 
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Figure 3-4. Storage and loss moduli of corneal tissues at preterm, neonatal and 
adult stages of development under frequency-sweep. 
 
 
 
 
 
 
Figure 3-5. Storage and loss moduli of scleral tissues at preterm, neonatal and 
adult stages of development under frequency-sweep. 
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Figure 3-6. Storage and Loss moduli of vitreous humor at preterm, neonatal and 
adult stages of development under frequency-sweep. 
 
 
 
 
 
 
Figure 3-7. The viscosity of vitreous humor with the shear rate at preterm, 
neonatal and adult stages of development.  
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Conclusions 
 
This research presented the data on the effects of shear strain sweep and 
frequency sweep on rheological properties of the porcine ocular tissues, and compared 
the differences in tissues at different stages of development. Storage and loss modulus of 
porcine ocular tissues (cornea, sclera and vitreous) differed at different stages of 
development (adult, neonatal and preterm), adult tissues being on the higher end of G′ 
and G″. Nevertheless, future studies are required to fully characterize the mechanical 
behaviors of the ocular tissues at different stages of development covering the entire age 
range, and with different diseases. A thorough understanding of the shear properties of 
the ocular tissues would facilitate in developing better treatments for complex diseases or 
abnormalities. 
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CHAPTER 4.    CONCLUSIONS 
 
 
A series of biodegradable hydrogels were synthesized by photopolymerization of 
NIPAAm monomer and hydrolytically degradable oligolactate DEX-Lactate-HEMA or 
HA-AEMA macromers. The thermoresponsive, rheological and biodegradable properties 
of the hydrogels were strongly dependent on the reaction conditions and composition of 
the hydrogels. The higher the amount of the Irgacure 2959 initiator, the higher the UV 
intensity, the longer the reaction time, and the higher amounts of crosslinker used for the 
synthesis, the higher the yield of the synthesized hydrogels. The hydrogels were not 
cytotoxic to DPSCs and ADSCs at a concentration up to at least 15 mg·mL-1, and have 
appropriate mechanical and biodegradable properties to promote DPSCs and ADSCs 
growth. Based on in vitro studies it was observed that DEX-gels and HA-gels appear to 
be suitable for encapsulation of DPSCs/ADSCs at optimum hydrogel concentration. The 
data confirmed that both DPSCs and ADSCs favorably adhered and proliferated within 
the biomaterials in vitro. Additionally, the current study confirmed that DPSCs and 
ADSCs have superior growth properties in HA-AEMA hydrogels compared to DEX-
Lactate-HEMA hydrogels. The developed hydrogels have shown promising potential for 
encpaulsating DPSCs/ADSCs for tissue engineering aplications. However, further 
optimization is needed to have apropriate mechanical and degradation properties to cater 
as per DPSCs or ADSCs growth inside their matrices, and successful completion of this 
project will have a significant impact on dental and retinal tissue engineering fields. 
 
This research presented the data on the effects of shear strain sweep and 
frequency sweep on rheological properties of the porcine ocular tissues, and compared 
the differences in tissues at different stages of development. Storage and loss modulus of 
porcine ocular tissues (cornea, sclera and vitreous) differed at different stages of 
development (adult, neonatal and preterm), adult tissues being on the higher end of G′ 
and G″. Nevertheless, future studies are required to fully characterize the mechanical 
behaviors of the ocular tissues at different stages of development covering the entire age 
range, and with different diseases. A thorough understanding of the shear properties of 
the ocular tissues would facilitate in developing better treatments for complex diseases or 
abnormalities. 
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APPENDIX.  RHEOLOGY DATA OF HYDROGELS AND PORCINE OCULAR 
TISSUES 
 
 
 
 
Figure A-1. Representative shear storage modulus (G′) and shear loss modulus 
(G″) as a function of oscillatory strain sweep for the HA-based 15 mg·mL-1 
hydrogel. 
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Figure A-2. Representative shear storage modulus (G′) and shear loss modulus 
(G″) as a function of oscillatory strain sweep for the HA-based 10 mg·mL-1 
hydrogel. 
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Figure A-3. Representative shear storage modulus (G′) and shear loss modulus 
(G″) as a function of oscillatory strain sweep for the Dex-based 15 mg·mL-1 
hydrogel. 
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Figure A-4. Representative shear storage modulus (G′) and shear loss modulus 
(G″) as a function of oscillatory strain sweep for the Dex-based 10 mg·mL-1 
hydrogel. 
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Figure A-5. Representative shear storage modulus (G′) and shear loss modulus 
(G″) as a function of frequency for the HA-based 15 mg·mL-1 hydrogel. 
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Figure A-6. Representative shear storage modulus (G′) and shear loss modulus 
(G″) as a function of frequency for the HA-based 10 mg·mL-1 hydrogel.  
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Figure A-7. Representative shear storage modulus (G′) and shear loss modulus 
(G″) as a function of frequency for the Dex-based 15 mg·mL-1 hydrogel.  
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Figure A-8. Representative shear storage modulus (G′) and shear loss modulus 
(G″) as a function of frequency for the Dex-based 10 mg·mL-1 hydrogel.  
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Figure A-9. Thermoresponsive phase transition and representative change in 
shear storage modulus (G′) and shear loss modulus (G″) as a function of 
temperature ramp for the HA-based 15 mg·mL-1 hydrogel. 
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Figure A-10. Thermoresponsive phase transition and representative change in 
shear storage modulus (G′) and shear loss modulus (G″) as a function of 
temperature ramp for the HA-based 10 mg·mL-1 hydrogel. 
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Figure A-11. Thermoresponsive phase transition and representative change in 
shear storage modulus (G′) and shear loss modulus (G″) as a function of 
temperature ramp for the Dex-based 15 mg·mL-1 hydrogel. 
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Figure A-12. Thermoresponsive phase transition and representative change in 
shear storage modulus (G′) and shear loss modulus (G″) as a function of 
temperature ramp for the Dex-based 10 mg·mL-1 hydrogel. 
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Figure A-13. Storage and loss moduli of corneal tissues at preterm stage of 
development under strain-sweep. 
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Figure A-14. Storage and loss moduli of corneal tissues at neonatal stage of 
development under strain-sweep. 
  
 64 
 
 
Figure A-15. Storage and loss moduli of corneal tissues at adult stage of 
development under strain-sweep. 
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Figure A-16. Storage and loss moduli of scleral tissues at preterm stage of 
development under strain-sweep. 
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Figure A-17. Storage and loss moduli of scleral tissues at neonatal stage of 
development under strain-sweep. 
  
 67 
 
 
Figure A-18. Storage and loss moduli of scleral tissues at adult stage of 
development under strain-sweep. 
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Figure A-19. Storage and Loss moduli of vitreous humor at preterm stage of 
development under strain-sweep. 
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Figure A-20. Storage and Loss moduli of vitreous humor at neonatal stage of 
development under strain-sweep. 
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Figure A-21. Storage and Loss moduli of vitreous humor at adult stage of 
development under strain-sweep. 
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Figure A-22. Storage and loss moduli of corneal tissues at preterm stage of 
development under frequency-sweep. 
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Figure A-23. Storage and loss moduli of corneal tissues at neonatal stage of 
development under frequency-sweep. 
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Figure A-24. Storage and loss moduli of corneal tissues at adult stage of 
development under frequency-sweep. 
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Figure A-25. Storage and loss moduli of scleral tissues at preterm stage of 
development under frequency-sweep. 
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Figure A-26. Storage and loss moduli of scleral tissues at neonatal stage of 
development under frequency-sweep. 
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Figure A-27. Storage and loss moduli of scleral tissues at adult stage of 
development under frequency-sweep. 
  
 77 
 
 
Figure A-28. Storage and Loss moduli of vitreous humor at preterm stage of 
development under Frequency-sweep. 
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Figure A-29. Storage and Loss moduli of vitreous humor at neonatal stage of 
development under Frequency-sweep. 
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Figure A-30. Storage and Loss moduli of vitreous humor at adult stage of 
development under Frequency-sweep. 
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Figure A-31. The viscosity of vitreous humor with the shear rate at preterm stage 
of development.  
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Figure A-32. The viscosity of vitreous humor with the shear rate at neonatal stage 
of development.  
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Figure A-33. The viscosity of vitreous humor with the shear rate at adult stage of 
development.  
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